egnite, Inc. Announces Research from its Real-World Database at Heart Rhythm 2023
Study Led by John Mignone, M.D., Ph.D., Presented at the Heart Rhythm Society’s Annual Meeting. Key Findings Demonstrate Increased Survival for Patients Receiving Combined Device and 4-Class Medical Therapy.
Ancora Heart Inc. and egnite, Inc. Announce Strategic Partnership to Accelerate Clinical Trial Enrollment for Heart Failure Patients
Use of artificial intelligence technology efficiently identifies eligible patient candidates for pivotal clinical trial; program launched at The Christ Health Network.
egnite Announces Portfolio Expansion to Reduce Stroke Risk in Atrial Fibrillation Patients
Expansion leverages a custom module to help health systems identify patients eligible for lifesaving therapy.
egnite, Inc. Announces Groundbreaking Research from its Database at American College of Cardiology Conference 2023
Two Bodies of Research Led by Philippe Généreux, MD and Colleagues were Presented Today at 2023 ACC Annual Meeting. Key Findings Demonstrate Increased Mortality Across All Degrees of Severity of Aortic Stenosis, Suggesting the Need to Re-Evaluate Currently Recommended Timing of Intervention, and Highlight the Importance of the Extent of
egnite, Inc. Announces A.I. Partnership with Leading Physicians to Elevate the Standard of Care for Patients with Cardiovascular Disease
Partnership leverages egnite’s artificial intelligence and big data expertise with Philippe Généreux and Linda Gillam from Morristown’s world-class Gagnon Cardiovascular Institute